Anti-obesity Drugs Market Share

Statistics for the 2023 & 2024 Anti-obesity Drugs market share, created by Mordor Intelligence™ Industry Reports. Anti-obesity Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Diabetes Care Drugs Research Obesity Treatment Market Market Share

Market Share of Anti-obesity Drugs Industry

The anti-obesity drug market is moderated due to the presence of companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold a significant market share and are well known, including GlaxoSmithKline PLC, Novo Nordisk AS, Pfizer Inc., F. Hoffmann-La Roche AG, and Bayer AG.

Anti-Obesity Drugs Market Leaders

  1. Vivus

  2. F Hoffmann-La Roche AG

  3. GlaxoSmithKline PLC

  4. Novo Nordisk AS

  5. Currax Pharmaceuticals LLC

*Disclaimer: Major Players sorted in no particular order

Anti-obesity Drugs Market Concentration

Anti-Obesity Drugs Market Report Snapshots

Anti-Obesity Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)